Align Technology: Moving From Sell To Neutral

Group 1 - Align Technology, Inc. (NASDAQ: ALGN) reported quarterly results that led to a significant decline in its stock price [2] - The company is categorized as a mid-cap dental medical device maker [2] - The discussion around covered call opportunities has been prevalent in the biotech sector recently [1] Group 2 - The Biotech Forum offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat for trade ideas and weekly research updates [2]